Related Experiment Videos
[Granulocyte alkaline phosphatase and myeloperoxidase in patients with ischemic heart disease]
Vrachebnoe Delo
|March 1, 1989
Insights
Alkaline phosphatase levels were high and myeloperoxidase levels were low in myocardial infarction patients. Monitoring these enzyme levels in leukocytes can help assess heart attack progression and treatment effectiveness.
Area of Science:
- Biochemistry
- Cardiology
- Hematology
Context:
- Chronic ischemic heart disease and myocardial infarction are significant cardiovascular conditions.
- Biomarkers play a crucial role in diagnosing and managing cardiac events.
Purpose:
- To investigate the levels of alkaline phosphatase and myeloperoxidase in patients with myocardial infarction.
- To determine the diagnostic and prognostic value of these enzymes in cardiac patients.
Summary:
- Patients with myocardial infarction exhibited elevated alkaline phosphatase levels.
- Conversely, myeloperoxidase levels were found to be decreased in myocardial infarction patients.
- Dynamic monitoring of leukocyte alkaline phosphatase and myeloperoxidase aids in assessing myocardial infarction progression and treatment efficacy.
Impact:
- Provides insights into the biochemical changes associated with myocardial infarction.
- Suggests potential use of alkaline phosphatase and myeloperoxidase as biomarkers for monitoring heart attack patients.
- Highlights the utility of dynamic enzyme evaluation in clinical practice for cardiovascular disease management.
Abstract:
Alkaline phosphatase and myeloperoxidase was examined in patients with chronic ischemic heart disease and myocardial infarction. It was established that patients with myocardial infarction showed high values of alkaline phosphatase while the values of myeloperoxidase were low. Dynamic evaluation of alkaline phosphatase and myeloperoxidase of leucocytes allows to assess the course of myocardial infarction and efficacy of its treatment.